atai Life Sciences N.V. (Nasdaq: ATAI), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, has announced that the company has entered into a term loan facility for up to $175 million with Hercules Capital, Inc. (NYSE: HTGC).
Latham & Watkins LLP represents atai in the transaction with a team led by New York corporate partner Nathan Ajiashvili and Bay Area finance partner Dan Van Fleet, with finance associates Hyunji Lee and Jude Baldo.
LEGAL DESIRE NEWSLETTER
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.